Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Looking for weekly quick income schedule examples? Learn how to plan effectively to increase your earnings and achieve financial success.
17,612 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
On tesla stock dropped tuesday, shares slid as investors weighed delivery expectations and a cautious analyst note. T...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
Bitcoin steadies above $61K after a dip to $59K. Pi Network’s PI hovers near its ATL threshold, signaling renewed vol...
When a company's chief financial officer sells stock, investors rightly pause. This article breaks down what the sale...
Polestar is barred from selling new cars in the United States under a new connected-vehicle rule, a move analysts say...
OpenAI teams with Broadcom to introduce its first custom AI accelerator, Jalapeño. The move signals a broader strateg...
A widower's online romance ended in a devastating financial hit. Learn how romance scams work, red flags to spot, and...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
NVIDIA faced a tougher first half in 2026 as the broader semiconductor sector surged. This piece breaks down why that...
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...